Infants of vaccinated mothers less likely to test positive for COVID-19

News
Article

COVID-19 vaccination during pregnancy may reduce infants’ risk of infection during the early months of life, according to a recent study.

Infants of mothers vaccinated during pregnancy had a lower risk of positive COVID-19 infection in the first 4 months of life than infants of unvaccinated mothers, according to findings in JAMA Internal Medicine.

The population-based cohort study, based in Norway, included 21,643 live births between September 1, 2021, and February 28, 2022. Nearly half of them (45%, n=9,739) were born to women who received a second or third dose of a COVID-19 during the last 2 trimesters of pregnancy.

Infants of those vaccinated during pregnancy were less likely to test positive for COVID-19 than infants of unvaccinated women, and less likely to test positive during the Delta surge (incidence rate, 1.2 vs 3.0 per 10,000 follow-up days; adjusted hazard ratio, 0.29; 95%CI, 0.19-0.46) than the Omicron surge (incidence rate, 7.0 vs 10.9 per 10,000 follow-up days; adjusted hazard ratio, 0.67; 95%CI, 0.57-0.79).

The study also showed a lower risk of infection among infants born to women who received a third dose of the vaccine than those who only received a second, suggesting a stronger level of protection after a booster dose.

Maternally transferred antibodies are critical in protecting a newborn infant from infection. While recent studies have shown that vaccinated women transfer COVID-19 antibodies in-utero and while breastfeeding, these study results provide further evidence to support the recommendation that pregnant women should receive the COVID-19 vaccine.

Originally published on our sister brand, Contemporary OB/GYN.

Reference:

Carlsen EØ, Magnus MC, Oakley L, et al. Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants. JAMA Internal Medicine. Published online June 1, 2022. doi:10.1001/jamainternmed.2022.2442

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Recent Videos
Potential downstream benefits of RSV preventive measures, with Octavio Ramilo, MD
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD, discusses impact of FDA's stricter COVID-19 vaccine policy for children
Related Content
© 2025 MJH Life Sciences

All rights reserved.